5334
K. K. Nanda, B. W. Trotter / Tetrahedron Letters 49 (2008) 5332–5335
Table 2 (continued)
OH2
H
Yielda (%)
66
Ph
F
F
Entry
Diamine
Product
Ph
F
F
N
F
N
NH2
Me
H
N
CF3
N
N
H
O
6
Me
N
OH2
1
6
H
N
NC
NC
H
H
N
NH2
CF3
Ph
Ph
OH
F
F
NH2
Me
F
N
7
80
72
N
N
N
H
N
Me
N
8
7
NH2
N
Ph
H2O
H
N
CF3
N
8
Ph
Ph
O
Ph
O
N
H+
OH
N
OH
N
Isolated yield from diamine. All compounds were >95% pure by 1H NMR and
a
were positively identified by HRMS analysis.
N
N
H
9
5
-CO2
(800 mg, 100%). The crude N-(2-anilinophenyl)-3,3,3-trifluoropro-
panamide (225 mg, 0.765 mmol) was dissolved in POCl3 (15 mL)
and heated at 100 °C for 3.5 h. The reaction mixture was then
cooled to room temperature and concentrated. The resulting vis-
cous residue was dissolved in dichloromethane (30 mL) and cooled
to 0 °C, and a saturated aqueous NaHCO3 solution was added
slowly until the aqueous layer became basic. The aqueous solution
was separated and extracted with dichloromethane (3ꢀ). The com-
bined organic solutions were dried over Na2SO4 and concentrated.
Purification by reversed phase HPLC (30 ꢀ 100 mm Phenomenex
Gemini (5–85% MeCN/water containing 0.05% NH4OH over
20 min at 50 mL/min) afforded 1-phenyl-2-(2,2,2-trifluoroethyl)-
1-H-benzimidazole as a white solid (205 mg, 97%). HRMS calcd
Ph
Ph
-H+
N
N
N
Me
Me
N
H
3
10
Scheme 2.
Table 2
Formation of 2-trifluoroethylbenzimidazoles
CF3
for
C
15H12F3N2 (M+H+): 277.0947; found 277.0948. 1H NMR
NH2
N
(500 MHz, CDCl3) d 7.87 (d, 1H, J = 8.08 Hz), 7.64–7.56 (m, 3H),
7.38–7.31 (m, 3H), 7.28 (dd, 1H, J = 7.75, 1.04 Hz), 7.12 (dd, 1H,
J = 8.10, 1.05 Hz), 3.67 (q, 2H, J = 9.87 Hz).
H
N
R1
N
ð4Þ
1. CF3CH2COCl
2. POCl3
R1
R2
R2
product
diamine
Acknowledgments
Entry Diamine
Product
Yielda
(%)
We thank Charles Ross and Joan Murphy for HRMS data.
NH2
Me
References and notes
H
CF3
N
N
1
94
Me
1. Kirk, K. L. J. Fluorine Chem. 2006, 127, 1013.
N
2. (a) Ng, R. A.; Guan, J.; Alford, V. C., Jr.; Lanter, J. C.; Allan, G. F.; Sbriscia, T.;
Linton, O.; Lundeen, S. G.; Sui, Z. Bioorg. Med. Chem. Lett. 2007, 784; (b) Ng, R. A.;
Guan, J.; Alford, V. C., Jr.; Lanter, J. C.; Allan, G. F.; Sbriscia, T.; Lundeen, S. G.; Sui,
Z. Bioorg. Med. Chem. Lett. 2007, 955; (c) Ng, R. A.; Lanter, J. C.; Alford, V. C., Jr.;
Allan, G. F.; Sbriscia, T.; Lundeen, S. G.; Sui, Z. Bioorg. Med. Chem. Lett. 2007,
1784.
3. (a) Ng, R.; Sui, Z.; Guan, J.; Lanter, J. C.; Alford, V. C., Jr. Novel Benzimidazole
Derivatives Useful As Selective Androgen Receptor Modulators (SARMS). WO
2006/039243 A1, 2006; (b) Liu, Z.; Milburn, C.; Page, D.; Walpole, C.; Yang, H.
Benzimidazole Derivatives, Compositions Containing Them, Preparation
Thereof And Uses Thereof. WO 2005/030762 A1, 2006; (c) Anderskewitz, R.;
Martyres, D.; Dollinger, H.; Pouzet, P.; Birke, F.; Bouyssou, T. Haloalkyl- and
Piperidine-Substituted Benzimidazole-Derivatives. WO 2005/019203 A1, 2005.
4. Brian, C. T.; Steer, J. T. J. Org. Chem. 2003, 68, 6814.
NH2
Ph
H
N
CF3
N
2
97
76
Ph
N
Me
NH2
Me
CF3
H
N
Me
Me
N
N
3
MeO2C
MeO2C
5. While POCl3 has not been previously employed in the synthesis of 2-
trifluoroethylbenzimidazoles, this reagent has been successfully used to
prepare non-fluorinated benzimidazoles by cyclodehydration. For example:
(a) Kurasawa, Y.; Shimabukuro, S.; Okamoto, Y.; Takeda, A. Heterocycles 1985,
23, 65; (b) Walser, A.; Flynn, T.; Mason, C. J. J. Heterocycl. Chem. 1991, 28, 1121;
(c) Stefancich, G.; Artico, M.; Corelli, F.; Massa, S. Synthesis 1983, 757.
6. South, M. S. J. Heterocycl. Chem. 1991, 28, 1013.
7. (a) Ramig, K.; Englander, M.; Kallashi, F.; Livchits, L.; Zhou, J. Tetrahedron Lett.
2002, 43, 7731; (b) Mechoulam, R.; Cohen, S.; Kaluszyner, A. J. Org. Chem. 1956,
21, 801; (c) Haider, N.; Wanko, R. Heterocycles 1994, 38, 1805; (d) Kobayashi, Y.;
Kumadaki, I.; Hirose, Y.; Hanzawa, Y. J. Org. Chem. 1974, 39, 1836; (e) King, J. F.;
Gill, M. S. J. Org. Chem. 1996, 61, 7250; (f) Uneyama, K.; Morimoto, O.
Tetrahedron Lett. 1989, 30, 109.
NH2
H
N
CF3
NH2
NH2
4
70
67
N
Me
H
N
CF3
N
5
Me
N
MeO
MeO